Ausführlicher Lebenslauf als PDF - hno arnoldner

More documents

Recommendations

Info

05/2005 “76th Annual Meeting of the German Society of Oto-‐‑Rhino-‐‑ Laryngology, Head and Neck Surgery”, Erfurt, Germany 04/2005 “MedEl Cochlear Implant Workshop“, Kitzbühel, Austria 11/2004 “9th European Workshop on Cochlear Implants, Auditory Brainstem Implants and Implantable Hearing Aids with Advanced Course on Bone-‐‑Anchored Hearing Aids”, Hannover, Germany 09/2004 “46th Annual Meeting of the Austrian Society of Oto-‐‑Rhino-‐‑ Laryngology, Head and Neck Surgery”, Linz, Austria 05/2004 “7th European Symposium on Paediatric Cochlear Implantation”, Geneva, Switzerland 04/2004 “Allergology in Otorhinolaryngology II“, Medical School Hannover, Germany 03/2004 “Allergology in Otorhinolaryngology I“, Medical School Hannover, Germany 01/2004 “1 st International Conference on Innovative approaches for Cochlear Implantation,” Vienna, Austria 06/2003 Symposium “25 years of Cochlear Implantation in Vienna”, Vienna, Austria 12/2003 “1st International Meeting of Cochlear Implantation in Infants and Toddlers”, Würzburg, Germany 09/2003 “47 th Annual Meeting of the Austrian Society of Oto-‐‑Rhino-‐‑ Laryngology, Head and Neck Surgery”, St. Pölten, Austria 11/2002 “MedEl Audiology Workshop 2002”, Kitzbühel, Tirol, Austria Wissenschaftliche Projekte und Förderungen Seit 2003 Mitglied der Otologie und Cochlea Implantat Forschungsgruppe AKH Wien, seither 28 Originalarbeiten, 3 Buchbeiträge, 96 Kongressbeiträge 2005 bis 2007 Principal investigator § 27 Studie: “A Randomised, Double-‐‑Blind, Placebo-‐‑Controlled, Clinical Dose-‐‑Ranging Trial to Evaluate Efficacy and Safety of a NMDA antagonist for Oral Administration in Patients with Subjective Tinnitus” 22 800 € (Fa. Merz, Deutschland) Seit 2010 Principal Investigator §27 Studie: “Effects of locally applied glucocorticoids and selective glucocorticoid receptor agonists on the inner ear in an animal model” 150 000 € (Fa. MedEl, Österreich) Seit 2011 Principal investigator (§27):
”A randomized double blind placebo controlled trial of intranasal submucosal bevacizumab in hereditary hemorrhagic telangiectasia” 10 000€ (Fa. Roche, Österreich) Seit 2011 Optimized topical glucocorticoid-‐‑therapy of the inner ear 188 748€ (FWF Einzelprojektförderung P-‐‑24260) Preise und Patente 2006 Wissenschaftspreis der Österreichischen Gesellschaft für H<strong>als</strong>-‐‑, Nasen-‐‑, Ohrenheilkunde 2006 Patent „Multichannel electrode for Cochlea Implants with a plurality of contracts distributed along the length of the electrode“ (WO 2008/022366 A1); 2008 Patent USA; Unites States Patent Application Cochlear Implant Pitch Intensity, Pub. No. US 2009/0012580 2011 Gewinner des A. Charles Holland Scholarships 2011 (Fa. Amplifon) Reviewer World Journal of Otorhinolaryngology (Editorial Board member) Laryngoscope Journal of the Acoustic Society of America (JASA) Wiener Klinische Wochenschrift European Journal of Neurology International Journal of Clinical Pharmacology and Therapeutics Organisierte Fortbildungsveranstaltungen (Faculty) Advanced Resident Temporal Bone Dissection Course, Vienna, October 4-‐‑6, 2010 3 rd International Interdisciplinary AOCMF Course on Skull Base Surgery, „Anterior Skull Base“, November 8–10, 2010 Vienna, Austria 4 th AOCMF Interdisciplinary International Course on Skull Base Surgery, „Lateral Skull Base“, September 28–30, 2011 Vienna, Austria
Page 1 and 2: Assoc. Prof. PD. Dr. Christoph Arno
Page 3: 04/2009 “Course in Objective Audi
Page 7 and 8: Peer reviewed journals: Publikation
Page 9 and 10: carcinoma cell lines of the head an
Page 11 and 12: 3. Hamzavi J, Baumgartner WD, Franz
Page 13 and 14: 8 th European Symposium on Pediatri
Page 15 and 16: 6th European Congress of Oto-‐
Page 17 and 18: 69. Arnoldner C Implantierbare Hör
Page 19: 93. Hamzavi S, Riss D, Arnoldner C

Ausführlicher Lebenslauf als PDF - hno arnoldner

Create successful ePaper yourself

Delete template?

Save as template?